Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions.

Hadi K, Walker LA, Guha D, Murali R, Watkins SC, Tarwater P, Srinivasan A, Ayyavoo V.

J Gen Virol. 2014 Mar;95(Pt 3):700-11. doi: 10.1099/vir.0.059576-0. Epub 2013 Dec 3.

2.

The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.

Wang J, Shackelford JM, Selliah N, Shivers DK, O'Neill E, Garcia JV, Muthumani K, Weiner D, Yu XF, Gabuzda D, Finkel TH.

DNA Cell Biol. 2008 May;27(5):267-77. doi: 10.1089/dna.2007.0707.

PMID:
18462066
3.

Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.

Zhou T, Dang Y, Baker JJ, Zhou J, Zheng YH.

Retrovirology. 2012 Nov 7;9:93. doi: 10.1186/1742-4690-9-93.

4.

HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest.

Liang Z, Liu R, Lin Y, Liang C, Tan J, Qiao W.

Virol Sin. 2015 Dec;30(6):441-8. doi: 10.1007/s12250-015-3654-8. Epub 2015 Dec 14.

PMID:
26676942
5.

Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.

Pham TN, Richard J, Gerard FC, Power C, Cohen ÉA.

J Virol. 2011 Dec;85(23):12254-61. doi: 10.1128/JVI.05835-11. Epub 2011 Sep 28. Erratum in: J Virol. 2012 Feb;86(3):1902.

6.

The role of Vpr in HIV-1 disease progression is independent of its G2 arrest induction function.

Lai M, Chen J.

Cell Cycle. 2006 Oct;5(19):2275-80. Epub 2006 Oct 1.

PMID:
16969134
7.

Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma.

Wang B, Ge YC, Palasanthiran P, Xiang SH, Ziegler J, Dwyer DE, Randle C, Dowton D, Cunningham A, Saksena NK.

Virology. 1996 Sep 1;223(1):224-32.

8.

Visualizing Vpr-induced G2 arrest and apoptosis.

Murakami T, Aida Y.

PLoS One. 2014 Jan 22;9(1):e86840. doi: 10.1371/journal.pone.0086840. eCollection 2014.

9.

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

Somasundaran M, Sharkey M, Brichacek B, Luzuriaga K, Emerman M, Sullivan JL, Stevenson M.

Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9503-8. Epub 2002 Jul 1.

10.

Genetic variance in the HIV-1 founder virus Vpr affects its ability to induce cell cycle G₂arrest and cell apoptosis.

Jianyuan Z, Jiwei D, Zeyun M, Jinming Z, Tao W, Shan C.

Yi Chuan. 2015 May;37(5):480-6. doi: 10.16288/j.yczz.15-004.

PMID:
25998437
11.

Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis.

Lum JJ, Cohen OJ, Nie Z, Weaver JG, Gomez TS, Yao XJ, Lynch D, Pilon AA, Hawley N, Kim JE, Chen Z, Montpetit M, Sanchez-Dardon J, Cohen EA, Badley AD.

J Clin Invest. 2003 May;111(10):1547-54.

12.

HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.

Andersen JL, Le Rouzic E, Planelles V.

Exp Mol Pathol. 2008 Aug;85(1):2-10. doi: 10.1016/j.yexmp.2008.03.015. Epub 2008 Apr 25. Review.

13.

HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.

Romani B, Shaykh Baygloo N, Aghasadeghi MR, Allahbakhshi E.

J Biol Chem. 2015 Jul 10;290(28):17380-9. doi: 10.1074/jbc.M115.641522. Epub 2015 Jun 1.

14.

Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.

Zimmerman ES, Sherman MP, Blackett JL, Neidleman JA, Kreis C, Mundt P, Williams SA, Warmerdam M, Kahn J, Hecht FM, Grant RM, de Noronha CM, Weyrich AS, Greene WC, Planelles V.

J Virol. 2006 Nov;80(21):10407-18. Epub 2006 Sep 6.

15.

Characterization of the molecular determinants of primary HIV-1 Vpr proteins: impact of the Q65R and R77Q substitutions on Vpr functions.

Jacquot G, Le Rouzic E, Maidou-Peindara P, Maizy M, Lefrère JJ, Daneluzzi V, Monteiro-Filho CM, Hong D, Planelles V, Morand-Joubert L, Benichou S.

PLoS One. 2009 Oct 19;4(10):e7514. doi: 10.1371/journal.pone.0007514.

16.

Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells.

de Silva S, Planelles V, Wu L.

PLoS One. 2012;7(5):e35385. doi: 10.1371/journal.pone.0035385. Epub 2012 May 3.

17.

Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells.

Yao XJ, Mouland AJ, Subbramanian RA, Forget J, Rougeau N, Bergeron D, Cohen EA.

J Virol. 1998 Jun;72(6):4686-93.

18.

Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection.

Alexander L, Weiskopf E, Greenough TC, Gaddis NC, Auerbach MR, Malim MH, O'Brien SJ, Walker BD, Sullivan JL, Desrosiers RC.

J Virol. 2000 May;74(9):4361-76.

19.

Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients.

Mologni D, Citterio P, Menzaghi B, Zanone Poma B, Riva C, Broggini V, Sinicco A, Milazzo L, Adorni F, Rusconi S, Galli M, Riva A; rHoPeS Group..

AIDS. 2006 Feb 28;20(4):567-74.

PMID:
16470121
20.

Supplemental Content

Support Center